0001209191-21-049110.txt : 20210802
0001209191-21-049110.hdr.sgml : 20210802
20210802175356
ACCESSION NUMBER: 0001209191-21-049110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210802
DATE AS OF CHANGE: 20210802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mainolfi Nello
CENTRAL INDEX KEY: 0001821189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 211137163
MAIL ADDRESS:
STREET 1: C/O KYMERA THERAPEUTICS, INC.
STREET 2: 200 ARSENAL YARDS, SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 300 TECHNOLOGY SQUARE
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-29
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001821189
Mainolfi Nello
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
1
1
0
0
Chief Executive Officer
Common Stock
2021-07-29
4
M
0
680
2.08
A
452879
D
Common Stock
2021-07-29
4
S
0
680
60.00
D
452199
D
Common Stock
2021-07-30
4
M
0
6279
2.08
A
458478
D
Common Stock
2021-07-30
4
S
0
6279
60.068
D
452199
D
Common Stock
2021-08-02
4
M
0
23456
2.08
A
475655
D
Common Stock
2021-08-02
4
S
0
21632
60.205
D
454023
D
Common Stock
2021-08-02
4
S
0
1524
61.2773
D
452499
D
Common Stock
2021-08-02
4
S
0
300
62.2082
D
452199
D
Stock Option (Right to Buy)
2.08
2021-07-29
4
M
0
680
0.00
D
2029-11-13
Common Stock
680
113166
D
Stock Option (Right to Buy)
2.08
2021-07-30
4
M
0
6279
0.00
D
2029-11-13
Common Stock
6279
106887
D
Stock Option (Right to Buy)
2.08
2021-08-02
4
M
0
23456
0.00
D
2029-11-13
Common Stock
23456
83431
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $61.00 to $61.98. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.205 to $62.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The shares underlying this stock option shall vest upon the achievement of specified performance-based milestones.
/s/ Bruce Jacobs, as Attorney-in-Fact
2021-08-02